Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Saved in:
| Title: | Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. |
|---|---|
| Authors: | Hess CN; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado., Szarek M; CPC Clinical Research, Aurora, Colorado.; The State University of New York Downstate Health Sciences University, Brooklyn., Anand SS; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada., Bauersachs RM; Department of Vascular Medicine, Klinikum Darmstadt, Darmstadt, and Center for Thrombosis and Hemostasis, University of Mainz, Mainz, Germany., Patel MR; Duke Clinical Research Institute, Division of Cardiology, Duke University Medical Center, Durham, North Carolina., Debus ES; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University of Hamburg-Eppendorf, Hamburg, Germany., Nehler MR; CPC Clinical Research, Aurora, Colorado.; University of Colorado School of Medicine, Department of Surgery, Aurora., Capell WH; CPC Clinical Research, Aurora, Colorado.; Division of Endocrinology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora., Beckman JA; Cardiovascular Division, Vanderbilt University Medical Center, Nashville, Tennessee., Piazza G; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Henkin S; Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Bura-Rivière A; Toulouse University Hospital, Toulouse, France., Lawall H; Praxis für Herzkreislaufkrankheiten und Akademie für Gefäßkrankheiten, Ettlingen, Germany., Roztocil K; Department of Transplantational Surgery, Institute of Clinical and Experimental Medicine, Prague, Czech Republic., Hsia J; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado., Muehlhofer E; Bayer, Research & Development, Wuppertal, Germany., Berkowitz SD; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado.; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora., Haskell LP; Janssen Research and Development, Raritan, New Jersey., Bonaca MP; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado. |
| Source: | JAMA network open [JAMA Netw Open] 2022 Jun 01; Vol. 5 (6), pp. e2215580. Date of Electronic Publication: 2022 Jun 01. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35731517 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hess+CN%22">Hess CN</searchLink>; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Szarek+M%22">Szarek M</searchLink>; CPC Clinical Research, Aurora, Colorado.; The State University of New York Downstate Health Sciences University, Brooklyn.<br /><searchLink fieldCode="AU" term="%22Anand+SS%22">Anand SS</searchLink>; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada.<br /><searchLink fieldCode="AU" term="%22Bauersachs+RM%22">Bauersachs RM</searchLink>; Department of Vascular Medicine, Klinikum Darmstadt, Darmstadt, and Center for Thrombosis and Hemostasis, University of Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Patel+MR%22">Patel MR</searchLink>; Duke Clinical Research Institute, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Debus+ES%22">Debus ES</searchLink>; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University of Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Nehler+MR%22">Nehler MR</searchLink>; CPC Clinical Research, Aurora, Colorado.; University of Colorado School of Medicine, Department of Surgery, Aurora.<br /><searchLink fieldCode="AU" term="%22Capell+WH%22">Capell WH</searchLink>; CPC Clinical Research, Aurora, Colorado.; Division of Endocrinology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora.<br /><searchLink fieldCode="AU" term="%22Beckman+JA%22">Beckman JA</searchLink>; Cardiovascular Division, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Piazza+G%22">Piazza G</searchLink>; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Henkin+S%22">Henkin S</searchLink>; Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.<br /><searchLink fieldCode="AU" term="%22Bura-Rivière+A%22">Bura-Rivière A</searchLink>; Toulouse University Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Lawall+H%22">Lawall H</searchLink>; Praxis für Herzkreislaufkrankheiten und Akademie für Gefäßkrankheiten, Ettlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Roztocil+K%22">Roztocil K</searchLink>; Department of Transplantational Surgery, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hsia+J%22">Hsia J</searchLink>; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Muehlhofer+E%22">Muehlhofer E</searchLink>; Bayer, Research & Development, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Berkowitz+SD%22">Berkowitz SD</searchLink>; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado.; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora.<br /><searchLink fieldCode="AU" term="%22Haskell+LP%22">Haskell LP</searchLink>; Janssen Research and Development, Raritan, New Jersey.<br /><searchLink fieldCode="AU" term="%22Bonaca+MP%22">Bonaca MP</searchLink>; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora.; CPC Clinical Research, Aurora, Colorado. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101729235%22">JAMA network open</searchLink> [JAMA Netw Open] 2022 Jun 01; Vol. 5 (6), pp. e2215580. <i>Date of Electronic Publication: </i>2022 Jun 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101729235 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-3805 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225743805%22">25743805 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Netw Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35731517 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamanetworkopen.2022.15580 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2215580 Titles: – TitleFull: Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hess CN – PersonEntity: Name: NameFull: Szarek M – PersonEntity: Name: NameFull: Anand SS – PersonEntity: Name: NameFull: Bauersachs RM – PersonEntity: Name: NameFull: Patel MR – PersonEntity: Name: NameFull: Debus ES – PersonEntity: Name: NameFull: Nehler MR – PersonEntity: Name: NameFull: Capell WH – PersonEntity: Name: NameFull: Beckman JA – PersonEntity: Name: NameFull: Piazza G – PersonEntity: Name: NameFull: Henkin S – PersonEntity: Name: NameFull: Bura-Rivière A – PersonEntity: Name: NameFull: Lawall H – PersonEntity: Name: NameFull: Roztocil K – PersonEntity: Name: NameFull: Hsia J – PersonEntity: Name: NameFull: Muehlhofer E – PersonEntity: Name: NameFull: Berkowitz SD – PersonEntity: Name: NameFull: Haskell LP – PersonEntity: Name: NameFull: Bonaca MP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2022 Jun 01 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2574-3805 Numbering: – Type: volume Value: 5 – Type: issue Value: 6 Titles: – TitleFull: JAMA network open Type: main |
| ResultId | 1 |